Invitro International IVRO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.03–0.11
- Bid/Ask
- $0.05 / $0.05
- Market Cap
- $767,331.60
- Volume/Avg
- 1,150 / 79,511
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 16
- Website
- https://www.invitrointl.com
Valuation
Metric
|
IVRO
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
IVRO
|
---|---|
Quick Ratio | 1.78 |
Current Ratio | 4.44 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
Metric
|
IVRO
|
---|---|
Return on Assets (Normalized) | −87.10% |
Return on Equity (Normalized) | −100.95% |
Return on Invested Capital (Normalized) | −100.95% |
Return on Assets
No chart available
Diagnostics & Research Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Jzmqhhqfl | Vqyb | $209.3 Bil | |
DHR
| Danaher Corp | Srwbpngjkv | Rgkyb | $174.8 Bil | |
IQV
| IQVIA Holdings Inc | Mlsjljywd | Fgjfqz | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Qqcjjltlb | Mhsmfsv | $41.0 Bil | |
A
| Agilent Technologies Inc | Pxkrznrx | Rqvf | $39.2 Bil | |
MTD
| Mettler-Toledo International Inc | Wrvfmvqvz | Tqzqm | $26.5 Bil | |
ICLR
| Icon PLC | Zqcmgvw | Bmnxxl | $25.2 Bil | |
ILMN
| Illumina Inc | Pqshgcrc | Rnbgkq | $19.8 Bil | |
WAT
| Waters Corp | Lymtbkxmjf | Xfqb | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Qxrmbwbpm | Szwkng | $17.1 Bil |